PUBLISHER: GlobalData | PRODUCT CODE: 1617668
PUBLISHER: GlobalData | PRODUCT CODE: 1617668
In recent years, the pharma industry has been taken over by a wave of digital transformation, leading to the integration of advanced technologies across different aspects of the pharma value chain.
Artificial intelligence (AI) and big data are at the forefront of driving innovation, from enhancing drug discovery to optimizing clinical trial design.
The drug discovery process is a very expensive and time-consuming process. Despite recent technological advancements, the success rate of research and development (R&D) is very low, adding emphasis to the need for innovative technologies, such as AI, to improve efficiency and outcomes.
This report consolidates GlobalData's latest thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact the AI in drug discovery, as well as providing insights into the leading players and future disruptors across the value chain, and providing insights into key drugs and markets from GlobalData's Pharma Intelligence Center. Additionally, this report is designed to provide strategic planners, competitive intelligence professionals and key stakeholders in the pharmaceutical industry a clear view of the opportunities and risks over the foreseeable future for AI.